Rein Therapeutics
RNTX
$1.65
Share price
-4.07%
Change (1 day)
-72.18%
Change (1 year)
Categories
EPS for Rein Therapeutics (RNTX)
EPS in 2024 (TTM): -$1.98
According to Rein Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.98. In 2023 the company made an earnings per share (EPS) of -$3.42 an increase over its 2022 EPS that were of -$6.02.
EPS history for Rein Therapeutics from 2015 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | -$1.98 | -42.11% |
| 2023 | -$3.42 | -43.19% |
| 2022 | -$6.02 | 2.21% |
| 2021 | -$5.89 | -51.72% |
| 2020 | -$12.20 | -49.17% |
| 2019 | -$24.00 | -43.93% |
| 2018 | -$42.80 | -29.61% |
| 2017 | -$60.80 | 82.33% |
| 2016 | -$33.35 | 40.54% |
| 2015 | -$23.73 |